Skip to content
10-K

Annual Report

ADMA BIOLOGICS, INC. ADMA

0001140361-26-006815

← back to feed
Filed
Feb 25, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 238.16M sh
Shares Diluted FY 2025 · Dec 31, 2025 244.9M sh
Shares Diluted FY 2025 · Dec 31, 2024 243.34M sh
Shares Diluted FY 2025 · Dec 31, 2023 223.98M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $31.94M
Stock Repurchased FY 2025 · Dec 31, 2024 $0
Stock Repurchased FY 2025 · Dec 31, 2023 $0
Capex FY 2025 · Dec 31, 2025 $22.58M
Capex FY 2025 · Dec 31, 2024 $8.23M
Capex FY 2025 · Dec 31, 2023 $4.77M
Operating Cash Flow FY 2025 · Dec 31, 2025 $50.4M
Operating Cash Flow FY 2025 · Dec 31, 2024 $118.67M
Operating Cash Flow FY 2025 · Dec 31, 2023 $8.8M
Long Term Debt FY 2025 · Dec 31, 2025 $69.33M
Long Term Debt FY 2025 · Dec 31, 2024 $72.34M
Short Term Debt FY 2025 · Dec 31, 2025 $2.81M
Short Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $87.63M
Cash And Equivalents FY 2025 · Dec 31, 2024 $103.15M
Stockholders Equity FY 2025 · Dec 31, 2025 $477.32M
Stockholders Equity FY 2025 · Dec 31, 2024 $349.02M
Stockholders Equity FY 2025 · Dec 31, 2023 $135.21M
Stockholders Equity restated FY 2025 · Dec 31, 2022 $151.97M
Current Liabilities FY 2025 · Dec 31, 2025 $69.54M
Current Liabilities FY 2025 · Dec 31, 2024 $55.54M
Total Liabilities FY 2025 · Dec 31, 2025 $146.92M
Total Liabilities FY 2025 · Dec 31, 2024 $139.66M
Current Assets FY 2025 · Dec 31, 2025 $466.51M
Current Assets FY 2025 · Dec 31, 2024 $331.41M
Total Assets FY 2025 · Dec 31, 2025 $624.24M
Total Assets FY 2025 · Dec 31, 2024 $488.68M
Total Assets FY 2025 · Dec 31, 2023 $329.18M
Eps Diluted FY 2025 · Dec 31, 2025 $0.60
Eps Diluted FY 2025 · Dec 31, 2024 $0.81
Eps Diluted FY 2025 · Dec 31, 2023 −$0.13
Eps Basic FY 2025 · Dec 31, 2025 $0.62
Eps Basic FY 2025 · Dec 31, 2024 $0.85
Eps Basic FY 2025 · Dec 31, 2023 −$0.13
Sga Expense FY 2025 · Dec 31, 2025 $91.58M
Sga Expense FY 2025 · Dec 31, 2024 $74.12M
Sga Expense FY 2025 · Dec 31, 2023 $59.02M
Rd Expense FY 2025 · Dec 31, 2025 $4.76M
Rd Expense FY 2025 · Dec 31, 2024 $1.81M
Rd Expense FY 2025 · Dec 31, 2023 $3.3M
Net Income FY 2025 · Dec 31, 2025 $146.93M
Net Income FY 2025 · Dec 31, 2024 $197.67M
Net Income FY 2025 · Dec 31, 2023 −$28.24M
Operating Income FY 2025 · Dec 31, 2025 $191.44M
Operating Income FY 2025 · Dec 31, 2024 $138.98M
Operating Income FY 2025 · Dec 31, 2023 $21.63M
Gross Profit FY 2025 · Dec 31, 2025 $292.77M
Gross Profit FY 2025 · Dec 31, 2024 $219.55M
Gross Profit FY 2025 · Dec 31, 2023 $88.94M
Cost Of Revenue FY 2025 · Dec 31, 2025 $217.41M
Cost Of Revenue FY 2025 · Dec 31, 2024 $206.9M
Cost Of Revenue FY 2025 · Dec 31, 2023 $169.27M
Revenue FY 2025 · Dec 31, 2025 $510.17M
Revenue FY 2025 · Dec 31, 2024 $426.45M
Revenue FY 2025 · Dec 31, 2023 $258.22M